Shape Memory Therapeutics, Inc.

Commercializing breakthrough neurovascular device based on shape memory polymers to treat cerebral aneurysms in a rapidly growing $1.5B market.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location College Station, TX, USA
  • Currency USD
  • Founded May 2009
  • Employees 4
  • Website shapemem.com

Company Summary

A medical device company developing innovative medical devices based on Shape Memory Polymer (SMP) materials exclusively licensed from Texas A&M and Lawrence Livermore National Labs. Initially targeting the cerebral aneurysm market with potential platform followers in other interventional treatments. SMT has broad IP with 12 issued & 15 pending patents. SMT has conducted preclinical studies and demonstrated biocompatibility and efficacy.

Team

  • Saurabh Biswas
    Exec VP, Operations

    10+ yrs. medical device experience, R&D and product strategy. New Ventures Manager , New Ventures Group., Texas A&M System Co-founder & CTO, CorInnova (Cardiac device). Co-founder Cologenomics Inc. (Cancer diagnostic). Awarded multiple international business plan awards in commercialization. PhD Biomedical Engineering - Texas A&M, MIT Sloan Executive Education.

  • James Lancaster
    CEO

    Previously CEO of Ecolyse, Inc. and the founding General Manager of the Research Valley Innovation Center. Lancaster has co-founded multiple technology companies in addition to the Research Valley Funds LLC. Lancaster currently serves on the boards of Ecolyse, Inc. and the non-profit BrightMinds Foundation. Lancaster holds a BBA from Texas A&M University and a MBA from The University of Texas at Austin.

  • Duncan Maitland
    CTO

    23 yrs. medical device experience, 15 issued patents. Associate Professor, Biomedical Engineering, Texas A&M University. Previously with Lawrence Livermore National Labs. Inventor of Endovasix EPAR (bought by large device company). Developed first shape memory polymer device taken into clinical trials with Micrus ( Presently J&J). $45M+ of R&D funding lifetime. PhD Biomedical Engineering, Northwestern University

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free